Note that this revision of the case fatality rate down to 0.94% is consistent with the non-Hubei CFR ratio calculated in the WHO's latest report:
https://www.who.int/docs/default-so...na-joint-mission-on-covid-19-final-report.pdf(Emphasis added.)
View attachment 516736
"As of 20 February, 2114 of the 55,924 laboratory confirmed cases have died (crude fatality ratio[CFR2]3.8%)(note: at least some of whom were identified using a case definition that included pulmonary disease). The overall CFR varies by location and intensity of transmission (i.e. 5.8%in Wuhan vs. 0.7%in other areas in China). In China, the overall CFR was higher in the early stages of the outbreak (17.3% for cases with symptom onset from 1-10 January) and has reduced over time to 0.7% for patients with symptom onset after 1 February (Figure 4). The Joint Mission noted that the standard of care has evolved over the course of the outbreak."
This estimate is in line with the mortality rate estimates I gave in the investor thread before I saw this report, but maybe some people will believe me more if they see the same figure in a WHO report.
Note that the 0.7% estimate is subject to both downward and upward biases - but my guess would be that there's still a significant upward bias in the mortality rate, because it's in the very best interest of mild cases to attempt to sit it out at home instead of subjecting themselves to weeks of quarantine and potential negative social stigma.
At this point it appears likely that while the coronavirus is more serious than regular flu which has an average mortality rate of 0.13%, the 0.70% figure and the much lower hospitalization rates are certainly much better than early estimates.
There's of course no telling how the markets will react to this next week - they might continue freaking out, or they might get greedy at the Fed news and at the improving stats of the coronavirus.
note that the end of the summary in this paper they stated:
(Paragraph revised 18 Feb.) With combined evidence about transmissibility and severity, as viewed through CDC’s Novel Framework for Assessing Epidemiologic Effects of Influenza Epidemics and Pandemics (Reed et al 2013), evidence to date points toward 2019-nCoV having the potential to have comparable severity to the 1918 flu pandemic in the absence of effective control and treatment, when averaged across all ages.
Last edited: